Home » Board Members » Leanne Blumenthal
An independent specialist pharmaceutical consultant with over thirty years post-qualification experience, Leanne has played a pivotal role in the South African pharmaceutical industry and is highly respected in her area of expertise.
She began her career at GlaxoSmithKline (GSK) then founded The GMP Co, offering training and specialised consulting services to leading pharmaceutical companies in South Africa. She provides the South African pharmaceutical industry (State and Private) with comprehensive consulting services across a broad spectrum of industrial pharmaceutical processes – in all areas of operation relating to medicine control, handling, registration and licencing, legislative requirements and all related issues. Her services concentrate mainly on compliancy issues, pre-audit preparations, local and international GMP Inspections / Quality Audits for the various International Statutory bodies, all legislative issues and all technical training.
Leanne played a role in setting up the first “legal” indoor medicinal Cannabis facility in South Africa, and has dedicated several years to researching and engaging with key Cannabis market players, developing a global network of blue chip funders, technical partners and pharma companies in the Cannabis industry. She provides consulting to Regulatory Authorities in different African countries on the Implementation of Cannabis for Medicinal Use Programs as well as the implementation of regulatory frameworks.
Highlights include: